Global Cardiac Pacemaker Market to Reach USD 7.0 Billion by 2033, Bolstered by Increasing Prevalence of CVDs

January 09, 2025 | Healthcare

According to the latest report by IMARC Group, titled "Cardiac Pacemaker Market by Type (Implantable, External), Technology (Biventricular, Single Chambered, Dual Chambered, and Others), Indication (Arrhythmias, Congestive Heart Failure, and Others), End User (Hospitals and Clinics, Ambulatory Surgery Centers, and Others), and Region 2025-2033," the global cardiac pacemaker market size reached USD 5.2 Billion in 2024. A cardiac pacemaker is a small, battery operated medical electronic device implanted in the chest or abdomen to regulate the heartbeat. It operates by sending electrical signals to the heart muscle, which causes it to contract and pump blood. It comprises electronic and mechanical components, including microprocessors, sensors, electrodes, wires, leads, and housing. It aids in reducing the risk of complications like stroke and heart failure that can be caused by an irregular and slow heart rate. Nowadays, a cardiac pacemaker can be customized according to the requirements of the patient. 


Global Cardiac Pacemaker Market Trends:

The surging prevalence of chronic diseases, such as arrhythmias, congenital heart disease, atrial fibrillation, and cardiovascular diseases (CVDs), represents one of the key factors catalyzing the demand for cardiac pacemakers around the world. Moreover, rising cases of heart failure on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses are augmenting the growth of the market. In addition, the growing geriatric population, which is more susceptible to these medical conditions, is influencing the market positively. Apart from this, leading players are launching small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant. They are also introducing cardiac pacemakers with longer battery life and remote monitoring capabilities that enable healthcare professionals to track the performance of the device and heart function of patients remotely utilizing a smartphone. Furthermore, the increasing awareness about the available treatment alternatives for heart-related diseases is creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of USD 7.0 Billion by 2033, exhibiting a CAGR of 3.29% during 2025-2033.


Market Summary:

  • On the basis of the type, the market has been bifurcated into implantable and external. Presently, implantable holds the largest market share.
  • Based on the technology, the market has been segmented into biventricular, single chambered, dual chambered, and others. Dual chambered currently accounts for the biggest market share.
  • On the basis of the indication, the market has been categorized into arrhythmias, congestive heart failure, and others. At present, arrhythmias dominates the market.
  • Based on the end user, the market has been segregated into hospitals and clinics, ambulatory surgery centers, and others. Hospitals and clinics currently represented the biggest market segment.
  • Region wise, the market has been divided into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico and others); and the Middle East and Africa. Amongst these, North America (the United States and Canada) enjoys the leading position in the market.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., and Shree Pacetronix Ltd.

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Types Covered Implantable, External
Technologies Covered Biventricular, Single Chambered, Dual Chambered, Others
Indications Covered Arrhythmias, Congestive Heart Failure, Others
End Users Covered Hospitals and Clinics, Ambulatory Surgery Centers, Others
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cardiac Pacemaker Market to Reach USD 7.0 Billion by 2033, Bolstered by Increasing Prevalence of CVDs
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials